跳至主要内容
临床试验/TCTR20211018002
TCTR20211018002Unknown4 期

Intratympanic steroid injection versus systemic steroid for improving hearing in idiopathic sudden sensorineural hearing loss patients

/A0 个研究点目标入组 60 人开始时间: 2021年10月18日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1.Patients who have been diagnosed sudden sensorineural hearing loss by losing pure tone average within 40-70 decibels for at least 3 consecutive frequencies
  • 2.Onset starts within 7 days prior to hospital
  • 4.Must be idiopathic cause
  • 5.Never been treated this condition before
  • 6.Unilateral side
  • 7.can speak Thai

排除标准

  • 1. active conditions of external/middle ear disease
  • 2.History of surgery/trauma at head and neck area prior onset of symptom 1 month
  • 3.congenital hearing loss
  • 4.Poor controlled of underlying disease eg. poor controlled DMT2,ESRD
  • 5.History of Meniere disease
  • 6.History of radiotherapy/chemotherapy/ototoxic drugs usage prior onset of symptom 2 weeks
  • 7.underlying retrocochlear pathology
  • 8.active pulmonary tuberculosis/parasitic infestation
  • 9.severe osteoporosis, congestive heart failure, Cushing's syndrome, psychiatric disorders, glaucoma

研究者

发起方
/A

相似试验